Grants and Contributions:
Title:
Novel Antibiotic Formulation for Prophylaxis of Post-Surgical Infections
Agreement Number:
905903
Agreement Value:
$255,400.00
Agreement Date:
Apr 1, 2018 - Sep 30, 2019
Description:
An antibiotic film product will be developed that exhibits sustained-release delivery of high local concentrations of antibiotic at surgical sites for extended duration with limited systemic exposures and effective in experimental models of post-operative infection.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Victoria, British Columbia, CA V8R 5J2
Reference Number:
172-2018-2019-Q1-905903
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
818717308
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 30,400 dollars.
Amendment Date
Jan 11, 2019
Recipient's Legal Name:
Eupraxia Pharmaceuticals Inc.
Federal Riding Name:
Victoria
Federal Riding Number:
59041
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: